|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 196.52 USD | +0.52% |
|
-2.32% | +11.67% |
| 02-13 | Biogen Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-13-2026 10:30 AM | |
| 02-12 | Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 28.84B | |||||
| 82.42B | |||||
| 63.02B | |||||
| 54.86B | |||||
| 51.1B | |||||
| 20.12B |
- Stock Market
- Equities
- BIIB Stock
- Charts Biogen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition